overexpression screens can be used to explore gene function in Drosophila melanogaster, but to demonstrate their full potential, comprehensive and systematic collections of fly strains are required. Here we provide a protocol for high-throughput cloning of Drosophila open-reading frames (orFs) that are regulated by upstream activation sequences (uas sites); the resulting Gal4-inducible uas-orF plasmid library is then used to generate Drosophila strains by c31 integrase-mediated site-specific integration. We also provide details for Flp/FRT-mediated in vivo exchange of epitope tags (or regulatory regions) in the orF library strains, which further extends the potential applications of the library. these transgenic uas-orF strains are a useful resource to complement and validate genetic experiments performed with loss-of-function mutants and rna interference (rnai) lines. the duration of the complete protocol strongly depends on the number of orFs required, but embryos can be injected and balanced fly stocks can be established within ~7-8 weeks for a few genes.
IntroDuctIon
Loss-of-function approaches have been very powerful for determining gene function in Drosophila; in particular, genetic screens based on random mutagenesis have been instrumental in elucidating biological processes and delineating signal transduction pathways. More recently, targeted approaches such as the genome-scale generation of RNAi libraries have gained popularity 1 and RNAi lines are now widely available from various sources such as the Vienna Drosophila RNAi Center (VDRC, http://stockcenter.vdrc.at/control/main), the Transgenic RNAi Project (TRiP, http://www.flyrnai.org/TRiP-HOME.html) and Fly Stocks of National Institute of Genetics (NIG-Fly, http:// www.shigen.nig.ac.jp/fly/nigfly/).
A drawback of the loss-of-function approach for elucidating gene function is the lack of observable phenotypes for the majority of genes in conventionally used screening setups 2 . For many genes, this may be due to functional redundancy between related genes; for others, the reason may be the lack of suitably sensitive assays. Given that a large fraction of genes in Drosophila (and many other organisms) still have no known function, alternative approaches to characterize these genes are needed.
Gain-of-function analyses, such as overexpression and misexpression of genes, are a useful complement to loss-of-function studies. To date, such approaches have relied mainly on random insertions of transposons containing Gal4-inducible enhancerpromoter elements, which drive the expression of genes flanking the insertions [3] [4] [5] . A rare exception to this approach is the collection of transgenic strains that are specifically generated from a limited set of UAS-ORF constructs comprising 236 human genes 6 . A limitation of transposon-based approaches is that insertions do not target all available genes; therefore, screens using enhancerpromoter lines are typically far from saturating. Furthermore, it usually requires considerable effort to firmly establish whether the phenotype is caused by overexpression of nearby genes, by an effect of integration into that particular genomic locus or by a combination of both.
To overcome these limitations, we have designed a strategy ( Fig. 1) to generate a comprehensive UAS-ORFeome library to control the expression of transgenes in Drosophila 7 . The main features of this approach are as follows:
The use of sequence-verified ORFs cloned by using the 'Gateway' recombination cloning system. The presence of a DNA barcode in the transgenic construct, which facilitates the injection of pooled plasmids, for the generation and subsequent identification of transgenic fly strains. The use of the site-specific ΦC31 integrase method. The presence of specific FRT sites flanking the ORFs to allow in vivo 'swapping' of promoters and/or tags.
A pilot library consisting of an untagged ORF set and a 3×HA (hemagglutinin)-tagged set, altogether comprising ~650 unique genes, was used to screen for novel Wnt/Wg pathway components, and it led to the identification of three kinases as regulators of Wg signaling 8 . To increase the versatility of the library, we have further modified the expression vector and introduced 'swapping' elements (i.e., mutated FRT sites) to facilitate in vivo exchange of epitope tags and regulatory regions. This led to the development of the currently used destination vector pGW-HA.attB (ref. 7) (Fig. 2) .
Here we provide a detailed protocol for the high-throughput creation of UAS-ORF (i.e., UAS-hsp70-ORF) Drosophila strains for in vivo expression. Currently available fly strains can be searched and ordered through the Zurich ORFeome Project (http://www.flyorf.ch).
Applications
The approach presented in this paper can be used to generate individual transgenic strains, and it is scalable for the generation of genome-scale libraries of UAS-ORF strains. The most obvious application for such a large ORF library is its use in systematic overexpression screens to characterize gene functions through phenotypic readouts 8 . To increase output and specificity, many of these screens will probably be performed in sensitized genetic backgrounds, similar to loss-of-function screens. However, compared with loss-of-function screens, ORF-expressing fly strains potentially have greatly increased versatility through an expanded range of applications, and we have attempted to include features that would maximize the range of current and potential future applications. In addition to phenotypic characterization, the use of 3×HA epitope-tagged ORFs already allows for the analysis of protein localization, and for the analysis of interaction partners by mass spectrometry and chromatin immunoprecipitation assays. Furthermore, the inclusion of specifically altered FRT recombination sites allows any sequence-encoded N-or C-terminal modification to be made. Lines can thus be customized for an even wider range of applications simply by exchanging epitope tags or promoter regions. Some potential applications are BiFC (bimolecular fluorescence complementation) analysis and introduction of 'degron tags' 7, 9, 10 . Although the cloned genes introduced into our destination vector pGW-HA.attB are intended for expression in vivo, they can also be used in cultured Drosophila cells through co-transfection with a suitable GAL4 expression plasmid such as tubulin-GAL4 or by transferring the ORFs into other Drosophila cell culture expression vectors 8 . The flexibility of the Gateway cloning system further allows for the transfer of ORFs into other vectors, such as those used for bacterial or mammalian expression.
Limitations
Phenotypes obtained from expressing epitope-tagged transgenes must be evaluated carefully, and ideally they should be validated by other methods 11 , including loss-of-function analyses. Notably, expression of transgenes can result in dominant-negative effects, yielding the same phenotype as loss-of-function approaches. Despite the benefit of epitope tags for protein detection, tags may generate false positive or false negative phenotypes when compared with untagged proteins 7 . Overexpression of transgenes can cause mislocalization of proteins, and it can affect protein folding and protein complex assembly, which could potentially have far-reaching regulatory effects (for a recent review, see ref. 12) . Approaches that tag proteins in their endogenous loci are likely to be more reliable strategies for reflecting accurate subcellular localization 13 , but these endogenously tagged constructs cannot be used to screen for overexpression phenotypes, which we consider the main application of our ORF library. A limitation of our approach is that we are currently generating only a single transcript variant per gene, but the protocol provided here would allow other users to generate additional transcript variants. However, despite extensive transcriptional variation through alternative promoter use and splicing, more than half of Drosophila melanogaster genes produce only a single polypeptide 14 . Integration of a UAS-ORF transgene into an attP site and ccdB (control of cell death B). The final expression vector is generated by replacing the Gateway cassette with a specific ORF sequence. The cassette is flanked by two differently altered FRT sites FRT5 and FRT2. The vector further contains a GAL4-inducible 5×UAS-hsp70 promoter region (the hsp70 fragment provides a TATA box and a transcriptional start site), a loxP site and a white + marker. The ORFs will be tagged by a triple HA epitope, which is separated from the gene region by a flexible linker (FL) region of 24 aa. The 3′ UTR is a tubulin alpha 1 trailer. Note that the illustration shows an already barcoded destination vector, i.e., the randomized bar code is inserted between the trailer and the following attB sequence. (b) Integration of the UAS-ORF expression construct into an attP landing site. For our ORF library, we use the fly strain ΦX-86Fb, which provides an attP integration site on the 3rd chromosome and the ΦC31 integrase on the X chromosome. The attP site is marked with DsRFP, which is expressed in the eyes by the 3×P3 promoter. The in vivo situation after the integration is indicated in detail (except for the presence of an ampicillin-resistance marker). The individual transgenic strains are determined by identifying the ORF-specific barcodes (the primer pair is indicated by red arrows).
Experimental design ORF cloning systems.
No complete genome-wide ORF library for Drosophila is currently available; however, the Berkeley Drosophila Genome Project (BDGP) has generated a large collection of ORFs by using the 'Creator' recombination cloning system 15 . Side-byside comparison of fly strains generated with either Creator-or Gateway-cloned ORFs showed that the protein expression levels of the Gateway clones were generally higher; consequently, in vivo phenotypes, upon overexpression, were more reliably observed in the Gateway fly strains than in those using the Creator system 7 . In light of this, we opted to use the Gateway system to clone the Drosophila ORFs.
ORF template sequences. Coding sequences can be found and downloaded individually or in batches from various sources such as FlyBase (http://flybase.org/), Ensembl (http://www.ensembl.org) and NCBI (http://www.ncbi.nlm.nih.gov). The Drosophila Gold collection contains a large collection of cDNAs whose coding sequences perfectly match reference sequences. Alternatively, many ORFs can be cloned using cDNA prepared from embryos or adult tissues. Many of these resources are readily available from the Drosophila Genomics Resource Center (https://dgrc. cgb.indiana.edu/). In addition, for Drosophila ORFs that are single-exon, genomic DNA can be used as a convenient template for amplification. PCR strategy. We use a two-step PCR strategy (Fig. 3a) to amplify ORF sequences for cloning. The first PCR uses genespecific primers (see Reagent Setup) to introduce the Drosophila Kozak sequence CAAC before the initiator methionine codon 16 . A second amplification round with primers pDONR221_attB1 and pDONR221_attB2 introduces full-length attB1 and attB2 recombination sites into the PCR product, as instructed in the Gateway cloning manual. To improve the amplification efficiency, betaine is routinely included.
Purification and verification of PCR products. We purify PCR products using paramagnetic beads, which we have found to be suitable for high-throughput cloning applications. These beads can be prepared and used as previously described 17 , or commercially available kits such as the Agencourt AMPure XP beads (Becton Dickinson) can be used. Gateway cloning efficiency is reduced with increasing insert size, but gel purification of large ORFs (>3 kb) may increase the success rate compared with bead purification. Purified PCR products encoding fulllength ORFs are cloned into the pDONR221 entry vector and sequence-verified (Fig. 3 ). Our pilot library was sequenced with a combination of Sanger sequencing and Roche 454 sequencing. More recently, we have moved to Illumina MiSeq for full insert sequencing using dsDNA fragmentase (NEB) as a convenient and scalable method to fragment plasmid DNA (Fig. 3c) . Highthroughput sequence analysis can be carried out with published ORF assembly software 18 .
Key features of the pGW-HA.attB expression vector. Sequenceconfirmed ORF entry clones are transferred to the destination vector pGW-HA.attB using a Gateway LR reaction. Key features that we have incorporated into the pGW-HA.attB expression vector to maximize the potential applications of the transgenic flies ( Fig. 2a) are as follows:
A C-terminal tag: the collection is currently being generated without a stop codon and with a C-terminal 3×HA tag, which is useful for determining that the full-length protein is expressed using western blotting. The HA epitope tag was chosen for its small size, the availability of affordable reagents to detect it and the experience that many researchers have with it. C-terminal .2-1.5 kb) amplified with the two-step PCR strategy; a 5-µl aliquot of the final PCR product for each ORF was run on a 1.2% (wt/vol) agarose gel. Each ORF is visible as a single bright band without additional nonspecific bands. Note that some genes may produce more than one specific band owing to alternative transcripts. (c) Fragmentation of plasmids for high-throughput sequencing. Time scale of ORF entry clone plasmid pool digestion using a dsDNA fragmentase enzyme mixture. In this case, a 45-min digestion yields ideal fragmentation of the plasmids, with the majority of the plasmid pool being fragmented into small-molecular-weight fragments. (d) Strategy for high-throughput sequencing of ORFs. Individual ORF entry clones are pooled and fragmented, followed by high-throughput sequencing library preparation. We prefer to use a 'beads-in' protocol in which paramagnetic beads used to purify the DNA are kept in the reaction mix to increase the final yield of the library. tagging is used as it has been shown by others that N-terminal tags more commonly cause mislocalization of proteins 19 . Mutated FRT sites to facilitate domain swapping: This functionality enables researchers to easily replace the HA tag with other tags, such as fluorescent proteins (see section 'Tag or promoter swapping'). Promoters can also be exchanged using this approach.
Barcoding the pGW-HA.attB expression vector. Molecular barcoding using randomized duplex oligonucleotides facilitates the identification of plasmids and fly lines when applying pool injections. Introduction of a barcode into other regularly used expression vectors is an attractive option for any laboratory working with Drosophila, as pool injections would circumvent the more common and laborious single-injection approaches. The barcoding approach is conceptually similar to that used in yeast genomic screens 20 . Efficient barcoding is dependent on minimizing 'insertless' vector background. We achieve this by using a pGW-HA.attB vector containing a lacZ 'stuffer' gene in place of the barcode; when the vector is digested with appropriate enzymes (XhoI-HindIII, in our case) to release the stuffer fragment, the separation of a single-cut vector from a double-cut vector on an agarose gel is maximized-thereby facilitating efficient barcoding, which is based on ligation of randomized oligonucleotides.
Selection of a suitable attP integration site. ΦC31 integrasemediated site-specific integration of genetic elements into the Drosophila genome has rapidly become a standard method for transgenesis, and considerable resources are already available (see 'Drosophila reagents' section below). The ΦC31 integrase method (i) offers an efficient way to generate transgenic flies owing to a high integration rate, (ii) eliminates the need for mapping of the insertions and (iii) allows for better control of expression by using characterized attP integration sites [21] [22] [23] [24] [25] . For our ORF library, we prefer to use the integration site at cytological position 86F, using the previously generated attP insertion ZH-attP-86Fb (ref. 24 ; Fig. 2b) . We use this attP integration site combined with a codon-optimized ΦC31 integrase transgene inserted on the • X chromosome. The resulting line, ΦX-86Fb, displays a high transgene integration rate, relatively strong transgene expression, ease of scoring transgenic offspring owing to strong white marker expression, as well as good overall fitness and high fertility. We have detected some background expression during early embryonic development from this landing site and note that this could potentially affect phenotypic characterization with some ORFs.
Embryo injections with pooled plasmids. Injection of embryos with individual transgenes is time-consuming, and we have circumvented this limitation by pooling expression plasmids (typically one 96-well plate at a time). This pool size typically allows recovery of ~60% of the injected ORFs from 100 to 120 F 1 outcrosses per injection round of ~1,000 embryos. Accurate quantification of expression plasmids used for pooling is important to ensure equal representation of the transgenes in the offspring. Constructs that are not recovered in the offspring initially are pooled again, often together with other plasmids to keep the pool size optimal (~100 or more for our large-scale approach). Two or three rounds are typically needed to obtain most transgenes, at which point missing genes can be individually injected. The barcode information is used to identify the transgenes by singlefly PCR and Sanger sequencing (Fig. 2b) .
Tag or promoter swapping. We have included mutated FRT sites 26 in the pGW-HA.attB expression vector, which flank the Gateway cassette/ORF sequence (Fig. 2a) . This allows facile exchange of either the promoter or, more commonly, the epitope tag by crossing the original UAS-ORF-3×HA line with either epitope tag or promoter 'swapping' lines without the need of recloning 7 (see Fig. 4 for examples). The promoter/epitope tag lines have alternative sequences inserted at the same locus as the UAS-ORF transgenes (86F), and these lines also carry an hs-flp transgene necessary for the exchange reaction. The swapping events can be easily tracked by screening for specific marker situations, e.g., w + y + for the C-terminal exchange (Fig. 4b) . As already mentioned, the swapping option substantially increases the versatility of the ORF library, and we are in the process of expanding the repertoire of alternative tags (Fig. 4c) .
• 18 ) REAGENT SETUP Primer design As cloning of the ORF requires specific primer-binding sites, you will need to allow flexibility in primer design quality parameters. Set the optimum size as 22 nt (allowed range 19-32) and the melting temperature at 62 °C (allowed range 58-72 °C, using SantaLucia salt correction for T m determination). For other options, set 'PRIMER_ TASK=pick_cloning_primers' so that the Primer3 program designs the primers to amplify the whole coding sequence; set 'PRIMER_NUM_ RETURN=1' so that only one set of primers for each gene is designed; and Change the apple plates at least once a day. On the day of injection, change the plates twice before collecting the eggs for injection. Alternatively, transfer the flies to fresh fly food vials or bottles ~3 d before injection and transfer them to the cage 1 d before injection at the latest. Injection needle preparation We use the Narishige PN-30 needle puller to generate suitably formed needles from microcapillaries. The various settings should result in a slender taper while ensuring an appropriate stiffness. After pulling, the needles are opened and sharpened on a continuously watered tip grinder. Press the needle briefly on the rotating grinder until some backflow into the needle is observed. A sharp beveled tip is desired. Preparation of glass injection slides These are prepared immediately before use. Lean the slides against a raised object, take a Pasteur pipette filled with the heptane-Scotch solution and cover the glass slide twice in the middle region. Desiccation chambers Use conventional glass jars filled to one-third with silica gel as desiccation chambers, and keep the filled jars in an oven set at 115 °C. About 1 h before use, take the jar out from the oven, close it with a lid and keep it at ~18 °C to let it cool down. When the glass jar is used for drying the embryos, it should no longer feel warm to the touch. 1| Digest 15 µg of pGW-HA.attB containing a lacZ stuffer, with HindIII/XhoI at 37 °C for ~2 h.
2|
Separate the fragments on a 0.8% (wt/vol) agarose gel in TBE buffer. The digested vector is ~10 kb and the lacZ stuffer is ~3.1 kb.
3| Gel-purify the vector according to standard methods and quantify the DNA spectrophotometrically.  pause poInt DNA can be stored at −20 °C for an indefinite period.
4|
Set up a series of ligation reactions, each using a different insert:vector ratio, as tabulated below (including a negative control without barcode duplex oligo). Incubate the ligations for 1 h at 16 °C.
component amount per reaction Final
Cut vector~700 ng~700 ng 
5|
Determine the best insert:vector ratio by setting up test transformations in separate aliquots of DB3.1 or ccdB survival cells with 1 µl of the different ligation mixes. Plate the transformed cells on LB agar plates containing 100 µg/ml ampicillin, and incubate the plates overnight at 37 °C. Incubate the remaining ligation reactions overnight at 16 °C.
6|
On the next day, check the LB plates to determine which ligation gives the best signal-to-background ratio. Use this ligation to transform 50 samples of competent DB3.1 or ccdB survival cells (50-µl aliquots) with 2.5 µl of ligation mix each; combine the heat-shocked bacteria, add it to 100 ml of SOC medium and shake the mixture for 1 h at 37 °C. If preferred, electroporation can be used in place of heat-shock-based transformation.
7| Plate 10 and 100 µl of transformed bacteria in duplicate on LB agar plates containing 100 µg/ml ampicillin. Incubate the plates overnight at 37 °C. To the remainder of the transformed bacteria, add 500 ml of LB medium containing 75 µg/ml ampicillin and 10 µg/ml chloramphenicol and incubate the plates for another 16-19 h at 37 °C.
8|
On the next day, score the colony numbers on the LB plates to estimate the diversity of the barcoded plasmid library. If the diversity is acceptable, use the 500-ml overnight cultures to purify plasmid DNA with a maxi prep kit.  crItIcal step At least 50 times higher barcode diversity than the planned ORF clone number is recommended to minimize the occurrence of identical barcodes.  pause poInt DNA can be stored at −20 °C for an indefinite period.
cloning and sequence verification of orFs • tIMInG several days to weeks 9| Set up the following 25-µl PCR mix to amplify ORFs using gene-specific primer pairs and appropriate template DNA (see Experimental design and Reagent Setup). Gene-specific forward + reverse primers (1 µM each) 2.5 each 100 nM each 15| Perform transformations in 96-well conical PCR plates by using 20 µl of competent DH5α T1R cells (Invitrogen) and 2 µl of BP recombination reaction. Heat-shock the cells for 1 min at 37 °C in a thermal cycler, place the plates on ice and add 100 µl of SOC medium. Recover the cells at 37 °C for 60 min before plating 10-30 µl on 24-well plates containing 500 µl of LB agar containing 50 µg/ml kanamycin. To avoid excess drying of the 24-well agar plates, pack them into resealable polyethylene bags and incubate them overnight at 37 °C.
16|
On the next day, pick single clones into 96-well deep-well plates containing 1.3 ml of Terrific Broth medium containing 50 µg/ml kanamycin, and culture them for 22-24 h at 37 °C in a humidity-controlled environment to minimize evaporation.  pause poInt For storage of ORF clones as bacterial cultures, add sterile glycerol to a final concentration of 15% and store them at −80 °C for several years.
17| Purify the plasmid DNA using the Wizard SV 96 plasmid DNA purification system according to the manufacturer's instructions. Elute the plasmids with 100 µl of 10 mM Tris-HCl (pH 8.5) and measure plasmid concentrations on 96-well UV-compatible plates by using known concentrations of control plasmid DNA as standards.  pause poInt DNA can be stored at −20 °C for an indefinite period.
18|
Pool approximately equimolar amounts of each plasmid to ensure even sequencing coverage, and fragment 0.5-1 µg of plasmid DNA in a 20-µl dsDNA fragmentase reaction containing 1 µl of fragmentase enzyme mix for 45 min at 37 °C (Fig. 3) .
19|
Depending on the sequencing sample preparation kit used, perform end repair, A tailing and adapter ligation according to the manufacturer's instructions. Alternatively, plasmids can be Sanger-sequenced by using M13F and M13R primers. The presence of an insert can be verified by Bsp1407I (BsrGI) digestion. The sequencing library preparation is typically done by the sequencing service provider, but for a general protocol see Meyer and Kircher 28 .
Note that owing to the att recombination sites in the entry clone, Sanger sequencing does not often yield ideal sequencing quality.
 pause poInt Sequencing library can be stored at −20 °C for an indefinite period.
20|
Assemble the clone sequences with PrinSeS-C software 18 .
21|
Transfer the sequence-verified clones to barcoded pGW-HA.attB vector by adding 1.5 µl of the entry clone miniprep from
Step 17 (concentration ~50 µg/ml) to a Gateway LR cloning reaction (total volume 7.5 µl) and transform as described in Step 15. Select transformants on LB agar containing 100 µg/ml ampicillin.
22|
Pick single colonies into 96-well deep-well plates containing 1.3 ml of Terrific Broth medium and 100 µg/ml ampicillin. Culture the colonies for 20-24 h at 37 °C in a humidity-controlled environment to minimize evaporation.
23|
Purify the plasmids and measure the concentrations as in Step 17.
Barcode sequence determination of the plasmids • tIMInG 2 d 24| Organize cloned and sequence-verified ORF minipreps in 96-well plates and normalize the concentrations to ~100 ng/µl. Take a 3-µl aliquot from each well position of a 96-well plasmid miniprep plate and transfer it to sequencing wells.
25|
Sequence the barcodes using Sanger sequencing with primer tub-F2new to associate the specific barcode sequence with an individual ORF and a respective well position.
pooling and purification of orFs for microinjection • tIMInG 3 h 26| Pool ~5 µl of miniprep DNA from each well of a 96-well plate and clean it with a QIAfilter midi cartridge (Qiagen) as per the manufacturer's instructions to obtain injection-quality DNA. Adjust the pool concentration to 100 ng/µl for microinjection.  crItIcal step Equal representation of the clones in the pool and midiprep purification maximizes the recovery of all the transgenes.  pause poInt DNA pools can be stored at −20 °C for an indefinite period.
The number of embryos that have to be injected to subsequently recover a substantial number of different transgenic flies depends on several criteria, mainly the integration rate of the attP site used and the survival rate of the injected fly embryos. The line ΦX-86Fb scores well in both these aspects, and as a rule of thumb we inject ~10 'injection slides' per pool consisting of 100 constructs (on one slide we have ~100 embryos aligned, and thus we inject ~1,000 embryos). Generally, after the G 0 outcrosses, we recover ~60% of the pooled constructs as transgenic flies from ~100 F1 outcrosses. (Note that we use only injected males in G 0 and F 1 crosses to remove the integrase transgene located on the X chromosome.)
27| Change the plate of the fly cage with a fresh, prewarmed apple agar plate containing a fingertip-sized smear of yeast paste. Leave the cage for ~30 min at 25 °C. Repeat this step so that the plates are changed (and discarded) one or two times before proceeding to Step 28 for embryo collection. The plate for embryo collection should be left on the cage for ~30 min.
28|
Collect and then dechorionate the embryos in the injection room (set at ~18 °C) by adding bleach to embryos on the agar plate. Incubate the plate for ~4 min, and then briefly agitate to see whether the embryos detach from the agar.
29|
Start the water jet pump, which is connected to a conventional filter flask. Place a membrane filter onto the permeable plate on top of the flask and rinse the filter with tap water, which will be sucked into the flask.
30|
Pour dechorionated embryos from the agar plate onto the filter membrane by repeated rinsing. Wash the embryos on the membrane filter thoroughly with water. When the embryos start to clump together, stop washing, and then take the filter membrane with the embryos and start aligning them.
31|
Align the embryos directly on the filter membrane with a wet brush, side by side, about two embryo widths apart, in the same anterior-posterior orientation. After finishing one row (~50 embryos), start a second next to the first with the opposite anterior-posterior orientation. In this 'double row', the micropyles of all embryos should point to the midline (i.e., the posterior poles point to the outside), where they are accessible to the injection needle.  crItIcal step Leave enough space between the aligned embryos to prevent oxygen depletion.
32|
Cover one side of the glass injection slides with the sticky heptane-Scotch solution (e.g., with a Pasteur pipette).
Once the slides are dry, take them and gently press the glue-coated side against the double rows of aligned embryos until the embryos stick to the glass slides (one double row per glass slide).
33|
Place the slides into a cooled desiccation chamber, close the lid and incubate the slides for ~6 min or longer.  crItIcal step The appropriate desiccation time is crucial to the success of an injection experiment. If it is too short, embryos will almost immediately leak out after needle retraction. To evaluate the desiccation, we recommend covering a few embryos of the first slide with some oil and injecting these embryos. If an appropriate drying period has been achieved, overlay all the properly dried embryos.
34| Meanwhile, sharpen a needle on the grinder, load it with a small amount of DNA and fix it onto the needle holder. Stick the needle into a drop of oil, focus the tip of the needle and press the clear button of the FemtoJet. This allows for a rough evaluation of needle quality before injection (e.g., is the tip open wide enough, is the tip sharp or blunt).
35|
After drying the embryos, cover them with some halocarbon oil. To start injecting, focus the embryos and then the needle. Insert the needle into the embryo and retract the tip quickly back into the very posterior region to ensure that the injection mixture mainly flows into that part. We use continuous flow while injecting. After one row is injected, turn the slide to inject the opposite row.
postinjection procedures • tIMInG ~12 d 36| After injection, place the embryo slides into humid chambers (a Petri dish containing a Whatman paper soaked with water) and incubate the chambers at 18 °C for 2 d.
37| After ~48 h, collect the crawling larvae with a thin wire: heap up ~20 larvae to a clump-like aggregate in the covering oil, and then carefully reach with the wire under the clump and transfer the larvae to the yeast plug of a fly food vial. We generally put 80-120 larvae into one vial. ? trouBlesHootInG 38| Transfer the vials with collected larvae to 25 °C. After ~10 d, flies will start to eclose.
Identifying and establishing transgenic strains
• tIMInG ~4 weeks 39| Collect adult males from vials and discard the females. Cross two males with 3-4 y − w − virgin females per vial (= G 0 outcross; Fig. 5 ).  crItIcal step We use males in order to remove the ΦC31 integrase transgene, located on the X chromosome, with this and the subsequent F 1 outcross. Note that here we use two males per cross to increase the rate of fertile crosses (with two males almost all crosses will produce offspring). 42| Subject the PCR products to Sanger sequencing with the reverse primer attP-R, which binds downstream of the barcode sequence (Fig. 2b) .
40|

43|
After determining the exact barcode composition of the processed males, continue balancing only one fly strain per specific barcode. Recurring barcodes, which represent recurring transgenic lines, are discarded (i.e., we only process one strain per barcode (Step 39)). Figure 5 | Crossing scheme for establishing UAS-ORF strains. Two injected (inj.) males are crossed with several y − w − females because some males are sterile owing to the injection procedure. The use of males also removes the ΦC31 integrase. In the F 1 outcross, clonality is obtained by crossing one orange-eyed male with an appropriate balancer strain (i.e., TM3 Sb Ser). To produce the final stock, UAS-ORF-balanced siblings are crossed inter se.
 crItIcal step When working with 'high priority' ORFs, we recommend balancing at least two independently obtained transformants to ensure establishment of a homozygous transgenic strain. Occasionally, despite an identical transgene and an identical attP integration site, one strain cannot be made homozygous, whereas another can.
44|
After the molecular determination of the transgenic flies and sorting out recurring strains, establish balanced stocks by sibling crosses between flies of the genotype w + /TM3 Sb Ser (w + indicating the UAS-ORF transgene) using a few flies per gender (Fig. 5) . After a few days, these crosses are moved to 18 °C, without deliberately establishing homozygous stocks.
orF confirmation of transgenic strains (optional) • tIMInG ~2-3 d  crItIcal In previous steps, we presume that a specific ORF is present in a strain on the basis of the barcode sequence.
To formally demonstrate that this is the case, the corresponding ORF can be amplified from the strain and sequenced, although this is not obligatory.
45|
Several generations after the balanced stocks are established, take one fly per strain and subject it to a single-fly PCR protocol using the hsp-GW-F/HL1-R primer pair. The extension time for the polymerase is adjusted according to the assumed ORF length.
? trouBlesHootInG 46| Subject the PCR products to Sanger sequencing with the forward primer hsp-GW-F, which binds upstream of the ORF in the hsp70 promoter region and allows sequencing into the 5′ region of the ORF.
swapping the 3×Ha tag for other tags (optional) • tIMInG up to several weeks  crItIcal As an example of a further application of the UAS-ORF lines, we describe here the exchange of the standard 3×HA tag for an eGFP tag (Fig. 4b) . However, the same procedure can be used to swap in other tags or promoters.
47|
Cross 5-8 males carrying the ORF-3×HA transgene (homo-or heterozygous) with 10-15 virgins of the strain TSeGFP-86Fb (TS, tag swapping) per fly vial. The strain TSeGFP-86Fb provides the eGFP tag at cytological position 86Fb plus the necessary hs-FLP on the X chromosome.
48| After a period of egg-laying (~2 d), discard the adults to avoid later overcrowding. You can also transfer them to a fresh vial and thus create a second round of 'reagents' .
49|
Three days after setting up the crosses, place the vial into a 37 °C water bath and subject the larvae to a 40-min heat shock. You can repeat this heat-shock treatment on the following day to likely increase the efficiency of swapping.
50| Allow larvae to develop to adulthood, collect ~7 males from the offspring (y + w + ) and mate them with 10-12 y − w − virgin females.
51|
After egg-laying, transfer the flies to a fresh vial to generate a second screening vial.  crItIcal step Generally, we find only a very few y + w + males in a vial (in Step 52), and thus we recommend creating at least two vials for screening.
52|
Raise the progeny to adulthood and screen for y + w + males. Cross a single male with the 3rd chromosome-balancer virgin females and subsequently establish a balanced or homozygous stock. ? trouBlesHootInG ? trouBlesHootInG For troubleshooting individual steps of PCR cloning (Steps 9-13) and Gateway recombination (Steps 14-16), consult the troubleshooting sections in the corresponding manuals. Use gene expression information on FlyBase for selection of a suitable life-stage or tissue to maximize the likelihood of successful amplification of your gene of interest. If PCR remains unsuccessful, a synthetic ORF construct can be purchased. Helpful information on the fly procedures can be found elsewhere 25, 27 . Further troubleshooting advice can be found in table 1.
